✦ LIBER ✦

COX-2 Inhibitor and Non-Selective NSAID Use in Those at Increased Risk of NSAID-Related Adverse Events

✍ Scribed by Svetla Gadzhanova, Jenni Ilomäki, Elizabeth E. Roughead

Book ID: 120805633
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 308 KB
Volume: 30
Category: Article
ISSN: 1170-229X
DOI: 10.1007/s40266-012-0037-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of Ulcers by Esomeprazole in

Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors

✍ Scheiman, James M.; Yeomans, Neville D.; Talley, Nicholas J.; Vakil, Nimish; Cha 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 296 KB

Non-selective NSAIDs and COX-2 selective

Non-selective NSAIDs and COX-2 selective inhibitors: GI risk and use of proton pump inhibitor prophylaxis

✍ Joshua J. Ofman; Enkhe Badamgarav; Kevin Knight; James M. Henning; Katrine Wallc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Temporal Relationship between Use of NSA

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

✍ Dr Stephen P. Motsko, Karen L. Rascati, Anthony J. Busti, James P. Wilson, Jamie 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 130 KB

Evaluation of Risk Profiles for Gastroin

Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users

✍ Dr Deborah Layton, Patrick C. Souverein, Eibert R. Heerdink, Saad A. W. Shakir, 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 177 KB

Factors that Influence Prescribers in th

Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

✍ Gunnarsdóttir, Anna I. ;Kinnear, Moira 📂 Article 📅 2005 🏛 Springer 🌐 Dutch ⚖ 137 KB

GI safety of a non-selective nsaid vs a

GI safety of a non-selective nsaid vs a COX-2 inhibitor: equivalency of ibuprofen and celecoxib in an OTC setting

✍ Elizabeth Ashraf; Stephen. Cooper; Lawrence Marinucci; Geraldine Doyle; Roger Be 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 26 KB